AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for PD - Parkinson's Disease

Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease NCT07226284NA1 site📍 Minneapolis University of Minnesota · Tests: Vagal nerve stimulation, No intervention Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic. NCT07207096n/a1 site📍 London St. Mary's University, Twickenham · Tests: complementary medicine Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease NCT07536542NA1 site📍 Ankara Ankara University · Tests: Dual-Task Training LFP-based Parameter Prediction in DBS for Parkinson's Disease NCT07485621n/a1 site📍 Leuven Loes Laurijssen Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor NCT06993571NA1 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf · Tests: Active-tACS, Sham-tACS, Unlocked-tACS Serotonin Release in Premotor and Motor PD NCT05516732n/a1 site📍 Exeter University of Exeter · Tests: Positron Emission Tomography (PET) scan using CIMBI-36 tracer, Magnetic Resonance Imaging (MRI) Scan, Positron Emission… Parkinson's Disease in Type 1 Gaucher Disease NCT07886879n/a1 site📍 New York Icahn School of Medicine at Mount Sinai Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites📍 San Francisco📍 Stanford📍 Jacksonville Ashvattha Therapeutics, Inc. · Tests: 18F-OP-801 Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease NCT07281794n/a2 sites📍 Newcastle upon Tyne📍 Newcastle upon Tyne Northumbria University Real-world Patient Experiences With Inbrija® NCT07797790n/a2 sites📍 Altmünster📍 Graz Merz Therapeutics GmbH · Tests: Levodopa inhalation powder Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease NCT07299240NA1 site📍 Nanjing Jiangsu Province Nanjing Brain Hospital · Tests: Remote ischemic conditioning device, Sham remote ischemic conditioning A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease NCT07157735Phase 21 site📍 Cambridge Cambridge University Hospitals NHS Foundation Trust · Tests: dapansutrile, placebo Use of CereGate Therapy for Freezing of Gait in PD NCT05292794NA7 sites📍 Redwood City📍 Aurora📍 Miami CereGate Inc. · Tests: CereGate Software; BSN cDBS Programmer; BSN Burst Programmer Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD NCT06883266NA1 site📍 Fargo Sanford Health · Tests: transcranial direct current stimulation (tDCS), Sham (No Treatment) Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease NCT07567482NA1 site📍 Gatineau Centre intégré de santé et de services sociaux de l'Outaoua… · Tests: Exoskeleton [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD NCT06120049Phase 2, Phase 32 sites📍 Ghent📍 Leuven prof. dr. Koen Van Laere · Tests: [18F]-MFBG PET CT, [18F]-FE-PE2I PET CT or PET MRI, [123I]-MIBG SPECT CT, [18F]-MFBG PET dosimetry scans PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's NCT06151002n/a1 site📍 London University College London Hospitals Black and African Americans Connections to Parkinson's Disease (BLAAC PD) NCT06719583n/a12 sites📍 Birmingham📍 Gainesville📍 Chicago Michael J. Fox Foundation for Parkinson's Research LIFUS For Neurological Disorders NCT07417280NA1 site📍 Toronto University Health Network, Toronto · Tests: LIFUS, Sham LIFUS Motor and Cognitive Exercise in Parkinson's Disease. NCT07465107NA1 site📍 Copenhagen NV Annemette Lokkegaard · Tests: Motor-cognitive exercise, Usual Care D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression NCT07312110Phase 211 sites📍 Arendal📍 Lørenskog📍 Drammen Haukeland University Hospital · Tests: D-serine, Placebo The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease NCT06383247NA1 site📍 Hefei Anhui Medical University · Tests: transcranial magnetic stimulation A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease NCT07195825Phase 11 site📍 Shanghai Shanghai Xinzhi BioMed Co., Ltd. · Tests: Injecting BBM-P002 into the bilateral putamen Steps Against the Burden of Parkinson's Disease NCT07057219NA1 site📍 Randwick The University of New South Wales · Tests: Exercise, Exercise Effects of Transcranial Direct Current Stimulation Combined With Nordic Walking on Gait and Balance in Parkinson's Disease NCT07381907NA1 site📍 Belém Universidade Metodista de Piracicaba · Tests: Transcranial Direct Current Stimulation (tDCS), active, Sham transcranial Direct Current Stimulation, Standardized Nord… Home-based Gait and Balance Training in Patients With Movement Disorders NCT06617884NA1 site📍 Düsseldorf Forschungszentrum Juelich · Tests: Gait and balance training Differential Assessment of Hypertonia NCT06596187NA1 site📍 Taoyuan Chang Gung University · Tests: Continuous passive motion device (CPM) of ankle - fast, Continuous passive motion device (CPM) of ankle - slow A Study of Buntanetap in Participants With PD NCT07284784Phase 2, Phase 327 sites📍 Birmingham📍 Sun City📍 Fountain Valley Annovis Bio Inc. · Tests: buntanetap/posiphen Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD NCT07153692NA1 site📍 Hangzhou Wang Ping · Tests: tDCS, Conventional Dysphagia Treatment, sham tDCS PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease NCT04396873Phase 11 site📍 Bethesda National Institute of Mental Health (NIMH) · Tests: 11C-MC1, 11C-PS13, 18f-florbetaben
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy